NCT05349032

Brief Summary

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 27, 2022

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

2 months

First QC Date

April 21, 2022

Last Update Submit

April 21, 2022

Conditions

Inflammation

Keywords

infalmmationbioavailability

Outcome Measures

Primary Outcomes (1)

  • Bioavailability

    Blood Plasma

    0, 1, 2, 4, and 12 hours

Study Arms (5)

Meriva

OTHER

120 mg of curcumin in Meriva.

Dietary Supplement: Curcumin

Longvida

OTHER

120 mg of curcumin Longvida.

Dietary Supplement: Curcumin

NovaSol

OTHER

120 mg of curcumin NovaSol

Dietary Supplement: Curcumin

CurcElite

OTHER

120 mg of curcumin CurcElite

Dietary Supplement: Curcumin

UltaCur

OTHER

120 mg of curcumin Ultracur

Dietary Supplement: Curcumin

Interventions

CurcuminDIETARY_SUPPLEMENT

Oral supplement

CurcEliteLongvidaMerivaNovaSolUltaCur

Eligibility Criteria

Age21 Years - 49 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age and gender

You may not qualify if:

  • Cannot take any phytonutrient or curcumin supplement five days prior to commencement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

David Roberts

Charlottesville, Virginia, 22902, United States

RECRUITING

Related Publications (1)

  • Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med. 2018 Nov;16(6):367-374. doi: 10.1016/j.joim.2018.07.001. Epub 2018 Jul 4.

    PMID: 30006023RESULT

MeSH Terms

Conditions

Inflammation

Interventions

Curcumin

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DiarylheptanoidsHeptanesAlkanesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, Cyclic

Central Study Contacts

David Roberts, MPH

CONTACT

810777687research@epiceuticallabs.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2022

First Posted

April 27, 2022

Study Start

March 1, 2022

Primary Completion

April 30, 2022

Study Completion

June 1, 2022

Last Updated

April 27, 2022

Record last verified: 2022-04

Locations

US(1)